Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China flag China · Delayed Price · Currency is CNY
9.92
+1.65 (19.95%)
Oct 28, 2026, 3:04 PM CST

SHE:300006 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
902.76926.061,072836.44846.29559.43
Cash & Short-Term Investments
902.76926.061,072836.44846.29559.43
Cash Growth
-13.66%-13.62%28.18%-1.16%51.28%2.67%
Accounts Receivable
210.37252.92286.67339.21348.39445.38
Other Receivables
170.99149.15166.75268.73312.52539.13
Receivables
381.36402.08453.42607.94660.9984.51
Inventory
167.43161.33201.7171202.4157.77
Prepaid Expenses
-7.2911.33.582.664.5
Other Current Assets
25.8524.5831.5727.2133.2320.78
Total Current Assets
1,4771,5211,7701,6461,7451,727
Property, Plant & Equipment
239.68252.17274.92286.97339.92392.49
Long-Term Investments
360.99384.12378.28519.68522.71481.36
Goodwill
44.9544.9544.9532.9432.9432.94
Other Intangible Assets
132.73131.18181.83189.3184.11116.36
Long-Term Accounts Receivable
---34.0632.41-
Long-Term Deferred Tax Assets
155.5152.39128.24132.35116.58104.62
Long-Term Deferred Charges
61.7455.5240.3627.2463.3762.53
Other Long-Term Assets
30.6133.0437.1322.1517.649.47
Total Assets
2,5042,5752,8562,8913,0552,927

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
149.1893.4865.6237.949.6334.26
Accrued Expenses
27.6299.58110.77107.55110.39109.24
Short-Term Debt
205.12179.42242.91113.5121.5130
Current Portion of Long-Term Debt
-131.8102.752458-
Current Portion of Leases
-3.613.654.2630.255.41
Current Income Taxes Payable
-0.861.312.127.877.03
Current Unearned Revenue
12.713.2113.7917.8524.0413.07
Other Current Liabilities
234.33206.54260.8255.09299.51317.8
Total Current Liabilities
628.95728.49801.61562.27701.14666.8
Long-Term Debt
111.7157.2141.45126.5149-
Long-Term Leases
0.671.463.832.536.5733.9
Long-Term Unearned Revenue
4.864.456.296.399.0412.26
Long-Term Deferred Tax Liabilities
18.8819.0519.2919.264.471.68
Other Long-Term Liabilities
---51.76--
Total Liabilities
765.08810.65972.47768.71870.22714.65

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
1,0561,0561,0561,0561,0561,056
Additional Paid-In Capital
1,5041,5071,4831,4831,4751,459
Retained Earnings
-773.73-750.67-501.33-414.9-406.22-358.52
Comprehensive Income & Other
-63.53-56.23-162.53-43.77--
Total Common Equity
1,7231,7561,8752,0812,1242,156
Minority Interest
15.818.188.0441.5160.5255.78
Shareholders' Equity
1,7391,7641,8832,1222,1852,212
Total Liabilities & Equity
2,5042,5752,8562,8913,0552,927

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
317.51373.48494.59270.79365.27219.32
Net Cash (Debt)
585.26552.58577.51565.65481.02340.11
Net Cash Growth
8.18%-4.32%2.10%17.59%41.43%-
Net Cash Per Share
0.550.520.550.540.460.34
Filing Date Shares Outstanding
1,0531,0561,0561,0561,0561,056
Total Common Shares Outstanding
1,0531,0561,0561,0561,0561,056
Working Capital
848.45792.85968.491,0841,0441,060
Book Value Per Share
1.641.661.781.972.012.04
Tangible Book Value
1,5451,5801,6491,8581,9072,007
Tangible Book Value Per Share
1.471.501.561.761.811.90
Buildings
-408.44411.75413.99412.67412.67
Machinery
-660.32652.83646.2674.06664.11
Construction In Progress
-0.6172.463.784.09